Basic Information
RNALocate ID: | RLID:11004138 |
RNA Symbol: | hsa-miR-744-5p |
Localization: | Extracellular vesicle |
RNA Information
RNA Name: | hsa-miR-744 |
RNA ID: | miRBase:MIMAT0004945 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 22849433 |
Tissue/Cell Line: | HEK-293T cells |
Method: | Next-generation RNA sequencing |
Description: | The total numbers of reads >15 bp matching each miRNA were calculated. These values were then normalized to number of reads per million mapped (RPMM) in each library, to enable direct comparison of expression levels. As a measure of the relative levels of expression of individual miRNAs in cells and EVs, the log (base two) of the ratio of the read number in EVs over that in cells was calculated (log2 (EV/cell)). The miRNA expression data for cells and EVs is presented in Additional file 1: Table S1. Data are collected from Table S1. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002696 | Cytoplasm | Neural progenitor cells | 21363885 |
RLID:01002697 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01002698 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01002699 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01002700 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:11004134 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11004135 | Exosome | Plasma | 23663360 |
RLID:11004136 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11004137 | Exosome | K562 cells | 24460325 |
RLID:11004139 | Microvesicle | Plasma | 23077538 |
RLID:11004140 | Microvesicle | Seminal plasma | 23539611 |
RLID-D:11000216 | Exosome | Blood|Endothelial cells | |
RLID-D:11000721 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-744-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-68635 |
MNDR | hsa-miR-744-5p | Lymphoma | MNDR-E-MI-68636 |
MNDR | hsa-miR-744-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-68637 |
MNDR | hsa-miR-744-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-68638 |
MNDR | hsa-miR-744-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-68639 |
MNDR | hsa-miR-744-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-68640 |
MNDR | hsa-miR-744-5p | Her2-receptor positive breast cancer | MNDR-E-MI-68641 |
MNDR | hsa-miR-744-5p | Breast cancer luminal | MNDR-E-MI-68642 |
MNDR | hsa-miR-744-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-68643 |
MNDR | hsa-miR-744-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-68644 |
MNDR | hsa-miR-744-5p | Gastric cancer | MNDR-E-MI-68645 |
MNDR | hsa-miR-744-5p | Alzheimer disease | MNDR-E-MI-68646 |
MNDR | hsa-miR-744-5p | Bladder cancer | MNDR-E-MI-68647 |
MNDR | hsa-miR-744-5p | Dysautonomia familial | MNDR-E-MI-68648 |
MNDR | hsa-miR-744-5p | Leukemia | MNDR-E-MI-68649 |
MNDR | hsa-miR-744-5p | Cardiovascular disease | MNDR-E-MI-68650 |
MNDR | hsa-miR-744-5p | Carotid stenosis | MNDR-E-MI-68651 |
MNDR | hsa-miR-744-5p | Lung cancer | MNDR-E-MI-68652 |
MNDR | hsa-miR-744-5p | Parkinson disease | MNDR-E-MI-68653 |
MNDR | hsa-miR-744-5p | Basal-like breast cancer | MNDR-E-MI-68654 |
MNDR | hsa-miR-744-5p | Pituitary neoplasms | MNDR-E-MI-68655 |
MNDR | hsa-miR-744-5p | Pancreatic cancer | MNDR-E-MI-68656 |
MNDR | hsa-miR-744-5p | Williams syndrome | MNDR-E-MI-68657 |
MNDR | hsa-miR-744-5p | Rectum adenocarcinoma | MNDR-E-MI-68658 |
MNDR | hsa-miR-744-5p | Colon cancer | MNDR-E-MI-68659 |
MNDR | hsa-miR-744-5p | Colon adenocarcinoma | MNDR-E-MI-68660 |
MNDR | hsa-miR-744-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-68661 |
MNDR | hsa-miR-744-5p | Acromegaly | MNDR-E-MI-68662 |
MNDR | hsa-miR-744-5p | Glioblastoma | MNDR-E-MI-68663 |
MNDR | hsa-miR-744-5p | Glioma | MNDR-E-MI-68664 |
MNDR | hsa-miR-744-5p | Chordoma | MNDR-E-MI-68665 |
MNDR | hsa-miR-744-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-68666 |
MNDR | hsa-miR-744-5p | Osteosarcoma | MNDR-E-MI-68667 |
MNDR | hsa-miR-744-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-68668 |
MNDR | hsa-miR-744-5p | Liver cancer | MNDR-E-MI-68669 |
MNDR | hsa-miR-744-5p | Gastric adenocarcinoma | MNDR-E-MI-68670 |
MNDR | hsa-miR-744-5p | Pituitary adenoma | MNDR-E-MI-68671 |
MNDR | hsa-miR-744-5p | Lung adenocarcinoma | MNDR-E-MI-68672 |
MNDR | hsa-miR-744-5p | Thyroid carcinoma | MNDR-E-MI-68673 |
MNDR | hsa-miR-744-5p | Pancreatic adenocarcinoma | MNDR-E-MI-68674 |
MNDR | hsa-miR-744-5p | Carcinoma renal cell | MNDR-E-MI-68675 |
MNDR | hsa-miR-744-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-68676 |
MNDR | hsa-miR-744-5p | Clear cell renal cell carcinoma | MNDR-E-MI-68677 |
MNDR | hsa-miR-744-5p | Biliary tract cancer | MNDR-E-MI-68678 |
MNDR | hsa-miR-744-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-68679 |
MNDR | hsa-miR-744-5p | Esophageal cancer | MNDR-E-MI-68680 |
MNDR | hsa-miR-744-5p | T acute lymphoblastic leukemia | MNDR-E-MI-68681 |
MNDR | hsa-miR-744-5p | Acute t cell leukemia | MNDR-E-MI-68682 |
MNDR | hsa-miR-744-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-68683 |
MNDR | hsa-miR-744-5p | Fibromyalgia | MNDR-E-MI-68684 |
MNDR | hsa-miR-744-5p | Adenoma | MNDR-E-MI-68685 |
MNDR | hsa-miR-744-5p | Hepatocellular carcinoma | MNDR-E-MI-68686 |
MNDR | hsa-miR-744-5p | Rheumatoid arthritis | MNDR-E-MI-68687 |
MNDR | hsa-miR-744-5p | Barrett's adenocarcinoma | MNDR-E-MI-68688 |
MNDR | hsa-miR-744-5p | Hodgkin lymphoma | MNDR-E-MI-68689 |
MNDR | hsa-miR-744-5p | Neuromyelitis optica | MNDR-E-MI-68690 |
MNDR | hsa-miR-744-5p | Colorectal cancer | MNDR-E-MI-68691 |
MNDR | hsa-miR-744-5p | Nasopharynx carcinoma | MNDR-E-MI-68692 |
MNDR | hsa-miR-744-5p | Multiple myeloma | MNDR-E-MI-68693 |
MNDR | hsa-miR-744-5p | Nasopharyngeal cancer | MNDR-E-MI-68694 |
MNDR | hsa-miR-744-5p | Epstein-barr virus infections | MNDR-E-MI-68695 |
MNDR | hsa-miR-744-5p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-68696 |
MNDR | hsa-miR-744-5p | Stroke lacunar | MNDR-E-MI-68697 |
MNDR | hsa-miR-744-5p | Barrett's carcinogenesis | MNDR-E-MI-68698 |
MNDR | hsa-miR-744-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-68699 |
MNDR | hsa-miR-744-5p | Tubulovillous adenoma | MNDR-E-MI-68700 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ARHGAP5 | Homo sapiens | RR00122473 |
TOP